These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3261818)

  • 41. Inhibition of concanavalin A-induced human lymphocyte mitogenic factor (Interleukin-2) production by suppressor T lymphocytes.
    Northoff H; Carter C; Oppenheim JJ
    J Immunol; 1980 Oct; 125(4):1823-8. PubMed ID: 6967918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of cyclosporin A on IL-2 production and lymphocyte proliferation during infection of mice with lymphocytic choriomeningitis virus.
    Kasaian MT; Biron CA
    J Immunol; 1990 Jan; 144(1):299-306. PubMed ID: 1967265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, augments cyclosporin A inhibition of cytolytic T lymphocyte induction.
    Bowlin TL; Rosenberger AL; McKown BJ
    Clin Exp Immunol; 1989 Jul; 77(1):151-6. PubMed ID: 2504519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro immunosuppressive properties of spergualins to murine T cell response.
    Fujii H; Takada T; Nemoto K; Abe F; Fujii A; Takeuchi T
    J Antibiot (Tokyo); 1989 May; 42(5):788-94. PubMed ID: 2524464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of cyclosporine on secondary cytotoxic T lymphocyte responses.
    Kiziroglu F; Miller RG
    Transplantation; 1990 May; 49(5):961-5. PubMed ID: 2139987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrophages as targets for inhibition by cyclosporine.
    Benson A; Ziegler HK
    Transplantation; 1989 Apr; 47(4):696-703. PubMed ID: 2784875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway.
    Pereira GM; Miller JF; Shevach EM
    J Immunol; 1990 Mar; 144(6):2109-16. PubMed ID: 1968924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune suppression by lysosomotropic amines and cyclosporine on T-cell responses to minor and major histocompatibility antigens: does synergy exist?
    Schultz KR; Bader S; Nelson D; Wang MD; HayGlass KT
    Transplantation; 1997 Oct; 64(7):1055-65. PubMed ID: 9381529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dietary fatty acids influence the production of Th1- but not Th2-type cytokines.
    Wallace FA; Miles EA; Evans C; Stock TE; Yaqoob P; Calder PC
    J Leukoc Biol; 2001 Mar; 69(3):449-57. PubMed ID: 11261793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-1 and interleukin-2 production in resistant and susceptible inbred mice infected with Trypanosoma congolense.
    Mitchell LA; Pearson TW; Gauldie J
    Immunology; 1986 Feb; 57(2):291-6. PubMed ID: 3485076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IL-4 bypasses the immune suppressive effect of cyclosporin A during the in vitro induction of murine cytotoxic T lymphocytes.
    Heeg K; Gillis S; Wagner H
    J Immunol; 1988 Oct; 141(7):2330-4. PubMed ID: 3262657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclosporine-cimetidine interaction.
    D'Souza MJ; Pollock SH; Solomon HM
    Drug Metab Dispos; 1988; 16(1):57-9. PubMed ID: 2894956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunosuppressive mode of action of deoxyspergualin in mice, as compared with cyclosporine A and mizoribine.
    Okubo M; Masaki Y; Kamata K; Sato N; Inoue K; Umetani N
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1085-7. PubMed ID: 2784882
    [No Abstract]   [Full Text] [Related]  

  • 54. Levamisole meets sulfhydryl requirements of CTLL-2 cells and mediates enhanced proliferative response to mitogen stimulation without increasing interleukin-2 production.
    Obiri NI; Dupere SL; Pruett SB; Lackey A; Emma D; O'Connor TE
    J Biol Response Mod; 1990 Jun; 9(3):288-99. PubMed ID: 2380743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alleviation of immunosuppression in vitro by recombinant platelet factor 4.
    Katz IR; Thorbecke GJ; Zucker MB
    Int Immunol; 1992 Feb; 4(2):183-90. PubMed ID: 1535785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discodermolide--a new, marine-derived immunosuppressive compound. I. In vitro studies.
    Longley RE; Caddigan D; Harmody D; Gunasekera M; Gunasekera SP
    Transplantation; 1991 Oct; 52(4):650-6. PubMed ID: 1833864
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of 3H-histamine interaction with lymphocytes: receptor binding or uptake?
    Wang Y; Kristensen F; Joncourt F; Slauson DO; De Weck AL
    Clin Exp Immunol; 1983 Nov; 54(2):501-8. PubMed ID: 6652970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the rat.
    Kupiec-Weglinski JW; Heidecke CD; Araujo JL; Abbud-Filho M; Towpik E; Araneda D; Strom TB; Tilney NL
    Cell Immunol; 1985 Jun; 93(1):168-77. PubMed ID: 3158407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. B cell stimulatory factor 1 (interleukin 4) is sufficient for the proliferation and differentiation of lectin-stimulated cytolytic T lymphocyte precursors.
    Pfeifer JD; McKenzie DT; Swain SL; Dutton RW
    J Exp Med; 1987 Nov; 166(5):1464-70. PubMed ID: 3500262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclosporine-induced tolerance in experimental organ transplantation. Evidence of diminished donor-specific cytotoxicity relative to donor-specific proliferative response.
    Norin AJ; Kamholz SL; Pinsker KL; Emeson EE; Veith FJ
    J Immunol; 1987 Jul; 139(2):332-7. PubMed ID: 2955037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.